An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually ...
Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.
In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
FDA reexamine infant RSV therapies with Sanofi, AstraZeneca, and Merck amid safety concerns and data review under new FDA leadership.
Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need to know. Fact checked by Sarah Scott Within a week of Brian Hartnett and ...
Most children will contract RSV by the time they turn 2 years old. These preventative tips can help limit the spread. Respiratory syncytial virus (RSV) is a common—and extremely contagious—virus that ...
FDA officials have opened a safety review of two injectable RSV drugs used to protect babies and toddlers from the ...
The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...